Literature DB >> 3034996

Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine.

D C Borg, K M Schaich.   

Abstract

It is common practice in biochemical research to assume that iron bound to desferrioxamine (DFO) to form ferrioxamine (FOA) has been rendered inactive to subsequent redox chemistry within the range of physiological redox potentials, both in vitro and in vivo. However, plants and microorganisms can make iron metabolically available from ferrioxamine and closely related trihydroxamate siderophores, and at neutral pH, cyclic voltammetry of FOA demonstrates a reversible one-electron reduction at about -0.42 to -0.45 V (vs. normal hydrogen electrode), which is within the range of a number of reducing enzymes. We present evidence for the Fenton-like ability of FOA reduced by paraquat cation radicals to consume H2O2 and produce hydroxyl radicals (OH.) in the process. Similar reactions may explain previously reported potentiation of the oxidizing toxicity of paraquat in rats by high doses of DFO, as well as several other examples of prooxidant actions of DFO in vivo. We present the hypothesis that biphasic antioxidant/prooxidant behavior of DFO as a function of dose may be common with iron-catalyzed oxidizing reactions when mobile strong reducing agents are present. Hence, the real possibility of amplifying oxidizing damage must be considered when planning treatment with DFO, and failure of DFO to inhibit a particular response to oxidizing stress or its enhancement by DFO cannot, by itself, be considered sufficient evidence to rule out an iron-dependent process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3034996     DOI: 10.1016/s0748-5514(86)80004-6

Source DB:  PubMed          Journal:  J Free Radic Biol Med        ISSN: 0748-5514


  11 in total

1.  Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect.

Authors:  K Chopra; M Singh; N Kaul; K I Andrabi; N K Ganguly
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

2.  Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.

Authors:  M Poot; H Hoehn
Journal:  Hum Genet       Date:  1990-05       Impact factor: 4.132

3.  Mapping cyclic nucleotide-induced conformational changes in cyclicAMP receptor protein by a protein footprinting technique using different chemical proteases.

Authors:  N Baichoo; T Heyduk
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

4.  Effect of deferoxamine pretreatment on acute pneumonic pasteurellosis and neutrophil oxidative metabolism in calves.

Authors:  R F Slocombe; G L Watson; C R Killingsworth
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

5.  Pathology of warm ischaemia and reperfusion injury in adipomusculocutaneous flaps.

Authors:  H Nishikawa; S Manek; S S Barnett; A Charlett; C J Green
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

Review 6.  Oxidative stress responses in Escherichia coli and Salmonella typhimurium.

Authors:  S B Farr; T Kogoma
Journal:  Microbiol Rev       Date:  1991-12

7.  Effects of deferoximine on chondrocyte alkaline phosphatase activity: proxidant role of deferoximine in thalassemia.

Authors:  M Hatori; J Sparkman; C C Teixeira; M Grynpas; J Nervina; N Olivieri; I M Shapiro
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

8.  Effect of intravenous administration of antioxidants alone and in combination on myocardial reperfusion injury in an experimental pig model.

Authors:  Dimitrios N Nikas; Georgios Chatziathanasiou; Anna Kotsia; Nikos Papamichael; Christoforos Thomas; Michail Papafaklis; Katerina K Naka; Nikos Kazakos; Haralampos J Milionis; Kostas Vakalis; Christos S Katsouras; Vasiliki Mpoumpa; Theodoros Vougiouklakis; Lampros Michalis
Journal:  Curr Ther Res Clin Exp       Date:  2008-10

9.  Prooxidant activity of transferrin and lactoferrin.

Authors:  S J Klebanoff; A M Waltersdorph
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

10.  Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells.

Authors:  Yutaka Niihara; Junli Ge; Oded Shalev; Huiyuan Wu; Amy Tu; Kouichi R Tanaka
Journal:  BMC Clin Pharmacol       Date:  2002-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.